US 7335799
Hydroxyl compounds and compositions for cholesterol management and related uses
granted A61KA61K31/191A61K31/194
Quick answer
US patent 7335799 (Hydroxyl compounds and compositions for cholesterol management and related uses) held by Esperion Therapeutics, Inc. expires Mon Feb 21 2028 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Esperion Therapeutics, Inc.
- Grant date
- Tue Feb 26 2008 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 21 2028 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 18
- CPC classes
- A61K, A61K31/191, A61K31/194, A61K31/20, A61K31/23